Safety and efficacy of belimumab in systemic lupus erythematosus academic clinical practices

OBJECTIVE: Belimumab (Benlysta) is a human monoclonal antibody that inhibits soluble B-lymphocyte stimulator and was approved by the FDA for treatment of adults with systemic lupus erythematosus (SLE). This study evaluates the use and efficacy of belimumab in academic SLE practices. METHODS: Invitat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Rheumatol
Asıl Yazarlar: Hui-Yuen, Joyce S., Reddy, Arthi, Taylor, Jennifer, Li, Xiaoqing, Eichenfield, Andrew H., Bermudez, Liza M., Starr, Amy J., Imundo, Lisa F., Buyon, Jill, Furie, Richard A., Kamen, Diane L., Manzi, Susan, Petri, Michelle, Ramsey-Goldman, Rosalind, van Vollenhoven, Ronald F., Wallace, Daniel J., Askanase, Anca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031077/
https://ncbi.nlm.nih.gov/pubmed/26523030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.150470
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller